Article
Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma
22 Feb 2011
Abstract excerpt
BACKGROUND: Oral squamous cell carcinoma (OSCC) is the sixth most prevalent cancer worldwide. Cancer stem cells (CSC) model theoretically contribute to tumor growth, metastasis, and chemo-radioresistance. Cisplatin is a widely used chemotherapeutic agent for OSCC treatment. The aim of this study was to compare stemness genes expression in chemo-sensitive and chemo-resistant specimens and further explore the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
